Eplehef 25 Tablet contains Eplerenone 25 mg, a selective aldosterone receptor antagonist used primarily in the management of hypertension and heart failure. By competitively blocking aldosterone receptors in the distal renal tubules, Eplerenone promotes sodium and water excretion while conserving potassium, thereby reducing blood volume and lowering blood pressure. It is indicated for patients with essential hypertension and for reducing cardiovascular morbidity and mortality in patients with left ventricular dysfunction following myocardial infarction. Eplerenone is particularly beneficial in patients who exhibit aldosterone-mediated pathophysiology, such as fluid retention and cardiac remodeling. The recommended dosage should be individualized based on clinical response and renal function, with careful monitoring of serum potassium levels to avoid hyperkalemia. Contraindications include hyperkalemia, significant renal impairment, and hypersensitivity to the drug. Common adverse effects may include dizziness, hyperkalemia, and gastrointestinal disturbances. Eplehef 25 Tablet should be used cautiously in patients receiving other potassium-sparing diuretics, potassium supplements, or drugs that increase serum potassium. Regular monitoring of renal function and electrolytes is essential to ensure safety and efficacy during treatment.